Mirati Therapeutics, Inc.·4

Jun 23, 5:18 PM ET

Gallagher Carol Giltner 4

4 · Mirati Therapeutics, Inc. · Filed Jun 23, 2023

Insider Transaction Report

Form 4
Period: 2023-06-22
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-06-22+12,78412,784 total
    Exercise: $38.02Exp: 2023-06-22Common Stock (12,784 underlying)
  • Award

    Common Stock

    2023-06-22+7,5557,555 total
Footnotes (2)
  • [F1]This represents a Restricted Stock Unit grant with a vesting period of 3 years that vests 33% annually from grant date.
  • [F2]The shares subject to the Option shall vest and become exercisable in 36 equal monthly installments following the date of grant.

Documents

1 file
  • 4
    wk-form4_1687555072.xmlPrimary

    FORM 4